Estimated coefficients based on the selected model in Table 3. by Luis Alberiko Gil-Alana (14659817)

Estimated changes in risk of leptospirosis, Salvador, Brazil, 1996–2010. by Marcelo Cunha (12400935)

A: Bacteria species/ASVs exhibiting a significant change in relative abundance after exposure to sodium sulfite. by Sally V. Irwin (4521733)

Subjects:

Estimated annual percentage changes in age-standardized rates of DALYs and ASDR of IHD attributable to HSBP in asthma across 21 regions from 1990 to 2021. by Zhenhua Zhuang (11192745)

Subjects:

Rosuvastatin treatment decreases the levels of OVA-IgE and angiogenesis-related cytokines in the serum. by Lei Zhang (38117)

Factors related to health decision-making autonomy on own healthcare (N = 9249). by Tausi Seleman Haruna (21416765)

Subjects:

Results of the M-K test in different seasons (significant level is 0.05). by Wang Runke (13256851)

Subjects:

Divergence from transmitted/founder (TF) virus increases during ART-naïve infection and decreases on treatment. by Kelsie Brooks (8928044)

GO analysis of stage-salient genes in the order of decreasing significance (i.e, increasing p–value). by Sangeetha Muthamilselvan (8966006)

Task variability/correlations decrease independently of mean task activity removal step in fMRI data. by Takuya Ito (57473)

Image_1_The Contribution of Decreased Muscle Size to Muscle Weakness in Children With Spastic Cerebral Palsy.TIF by Britta Hanssen (4898155)

“…To define the contribution of decreased muscle size to muscle weakness, two cohorts were recruited in this cross-sectional investigation: 53 children with SCP [median age, 8.2 (IQR, 4.1) years, 19/34 uni/bilateral] and 31 children with a typical development (TD) [median age, 9.7 (IQR, 2.9) years]. …”

Table_2_The Contribution of Decreased Muscle Size to Muscle Weakness in Children With Spastic Cerebral Palsy.docx by Britta Hanssen (4898155)

“…To define the contribution of decreased muscle size to muscle weakness, two cohorts were recruited in this cross-sectional investigation: 53 children with SCP [median age, 8.2 (IQR, 4.1) years, 19/34 uni/bilateral] and 31 children with a typical development (TD) [median age, 9.7 (IQR, 2.9) years]. …”

Table_3_The Contribution of Decreased Muscle Size to Muscle Weakness in Children With Spastic Cerebral Palsy.docx by Britta Hanssen (4898155)

“…To define the contribution of decreased muscle size to muscle weakness, two cohorts were recruited in this cross-sectional investigation: 53 children with SCP [median age, 8.2 (IQR, 4.1) years, 19/34 uni/bilateral] and 31 children with a typical development (TD) [median age, 9.7 (IQR, 2.9) years]. …”

Table_1_The Contribution of Decreased Muscle Size to Muscle Weakness in Children With Spastic Cerebral Palsy.docx by Britta Hanssen (4898155)

“…To define the contribution of decreased muscle size to muscle weakness, two cohorts were recruited in this cross-sectional investigation: 53 children with SCP [median age, 8.2 (IQR, 4.1) years, 19/34 uni/bilateral] and 31 children with a typical development (TD) [median age, 9.7 (IQR, 2.9) years]. …”

Three-dimensional topography of concrete joints. by Zhezhe Zhang (19704587)

Subjects:

Test results under the UNLCSL path. by Zhezhe Zhang (19704587)

Subjects:

Test scheme. by Zhezhe Zhang (19704587)

Subjects:

Preparation process of concrete joint specimens. by Zhezhe Zhang (19704587)

Subjects:

Cohesion correction coefficient. by Zhezhe Zhang (19704587)

Subjects:

Fig 18 in each curve fitting results. by Zhezhe Zhang (19704587)

Subjects: